Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

A better understanding of the anti-SARS-CoV-2 immune response is necessary to finely evaluate commercial serological assays but also to predict protection against reinfection and to help the development of vaccines. For this reason, we monitored the anti-SARS-CoV-2 antibody response in infected pati...

Full description

Bibliographic Details
Main Authors: Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Microbiology
Subjects:
SARS-CoV-2
COVID-19
spike
nucleocapsid
neutralizing antibodies
vaccine
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2020.584251/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2020.584251/full

Similar Items